Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 6, 2010, Pages 596-602

  Huang, Zhao ^a   Wang, Si Rong ^a   Su, Wei ^a   Liu, Ji Yun ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Absorption; Cytokine; Hemoperfusion; Severe sepsis

Indexed keywords

DOBUTAMINE; DOPAMINE; HEMOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FEMALE; HEART INDEX; HEART RATE; HEMATOLOGY; HEMOPERFUSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LIVER FAILURE; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; SURVIVAL; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTE COUNT; THROMBOPLASTIN TIME;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; FEMALE; HEART RATE; HEMOPERFUSION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; INTERLEUKIN-8; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVAL; TIME FACTORS;

EID: 78651519727     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00825.x     Document Type: Article

References (20)

1. Cohen J. Sepsis and septic shock: inching forwards. Clin Med 2009;9:256-7.
2. Graziani G, Bordone G, Bellato V et al. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study. J Nephrol 2006;19:176-82.
3. Ianaro A, Tersigni M, D'Acquisto F. New insight in LPS antagonist. Mini Rev Med Chem 2009;9:306-17.
4. Schmitz D, Wilsenack K, Lendemanns S et al. beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 2007;72:286-94.
5. Suyama H, Kawasaki Y, Morikawa S, Kaneko K, Yamanoue T. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury. Hiroshima J Med Sci 2008;57:79-84.
6. Tsushima K, Kubo K, Yoshikawa S et al. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial 2007;11:138-45.
7. Kushi H, Miki T, Nakahara J et al. Hemoperfusion with an immobilized polymyxin B fiber column improves tissue oxygen metabolism. Ther Apher Dial 2006;10:430-5.
8. Hu XB, Gao HB, Liao ME et al. The use of HA330-II microporous resin plasma adsorption in the treatment of chronic severe hepatitis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007;19:760-1.
9. Li G, Yang B, Li C et al. Studies on adsorption of the organic phosphorus pesticide with the macroporous resin. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2000;17:369.
10. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
11. Ventetuolo CE, Levy MM. Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008;29:591-603.
12. Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008;15:581.
13. Cruz DN, Antonelli M, Fumagalli R. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-52.
14. Kulabukhov VV. Use of an endotoxin adsorber in the treatment of severe abdominal sepsis. Acta Anaesthesiol Scand 2008;52:1024-5. Epub 2008 May 20.
15. Hirasawa H, Oda S, Matsuda K. Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol 2007;156: 365-70.
16. Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther 2007;26(Suppl 1):13-19.
17. Mourão MP, Lacerda MV, Macedo VO et al. Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon. Platelets 2007;18:605-12.
18. Vincent JL. Organ dysfunction in patients with severe sepsis. Surg Infect 2006;7(Suppl 2):S69-71.
19. Csomos A, Szentkereszty Z, Fülesdi B. Cost differences in the treatment of severe sepsis between survivors and non-survivors on the first day of intensive care admission. Orv Hetil 2007;148:1851-6.
20. Carneiro AV, Lopes MG, De Pádua F. Rational distribution of resources in intensive medicine. Analysis of admission and discharge criteria at intensive care units. Acta Med Port 1997;10:761-70.